{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:25:01Z","timestamp":1783488301451,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Education, Science and Technological Development, Republic of Serbia","award":["451-03-9\/2021-14\/200161"],"award-info":[{"award-number":["451-03-9\/2021-14\/200161"]}]},{"name":"Ministry of Education, Science and Technological Development, Republic of Serbia","award":["451-03-66\/2024-03\/200110"],"award-info":[{"award-number":["451-03-66\/2024-03\/200110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02556-x","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:31:47Z","timestamp":1742283107000},"page":"1333-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of non-cholesterol sterols and fatty acids in patients with graves\u2019 orbitopathy: insights into lipid metabolism in relation to the clinical phenotype of disease"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-8885","authenticated-orcid":false,"given":"Marija Sari\u0107","family":"Matutinovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vladimirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Gojkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Djuri\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"\u0106iri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"\u017darkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Ignjatovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Kahaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Nedeljkovi\u0107-Beleslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"2556_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362:726\u2013738","journal-title":"N Engl J Med"},{"key":"2556_CR2","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.1016\/j.beem.2022.101620","volume":"37","author":"ACH Lee","year":"2023","unstructured":"Lee ACH, Kahaly GJ (2023) Pathophysiology of thyroid-associated orbitopathy. Best Pract Res Clin Endocrinol Metab 37:101620","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2556_CR3","doi-asserted-by":"publisher","first-page":"615993","DOI":"10.3389\/fendo.2020.615993","volume":"11","author":"L Bartalena","year":"2020","unstructured":"Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML (2020) Epidemiology, natural history, risk factors, and prevention of graves\u2019 orbitopathy. Front Endocrinol (Lausanne) 11:615993","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2556_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","volume":"55","author":"AJ Dickinson","year":"2001","unstructured":"Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf) 55:283\u2013303","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2556_CR5","volume-title":"Graves orbitopathy","author":"TJ Fox","year":"2022","unstructured":"Fox TJ, Anastasopoulou C (2022) Graves orbitopathy. StatPearls Publishing, Treasure Island (FL)"},{"key":"2556_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.autrev.2017.12.012","volume":"17","author":"A Bruscolini","year":"2018","unstructured":"Bruscolini A, Sacchetti M, La Cava M, Nebbioso M, Iannitelli A, Quartini et al (2018) Quality of life and neuropsychiatric disorders in patients with graves\u2019 orbitopathy: current concepts. Autoimmun Rev 17:639\u2013643","journal-title":"Autoimmun Rev"},{"key":"2556_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0035-1555762","volume":"47","author":"RS Bahn","year":"2015","unstructured":"Bahn RS (2015) Current insights into the pathogenesis of graves\u2019 ophthalmopathy. Horm Metab Res 47:773\u2013778","journal-title":"Horm Metab Res"},{"key":"2556_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00417-021-05456-x","volume":"260","author":"J Cao","year":"2022","unstructured":"Cao J, Su Y, Chen Z, Ma C, Xiong W (2022) The risk factors for graves\u2019 ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 260:1043\u20131054","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2556_CR9","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C (2021) The 2021 European group on graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of graves\u2019 orbitopathy. Eur J Endocrinol 185:G43\u201367","journal-title":"Eur J Endocrinol"},{"key":"2556_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S2213-8587(21)00238-2","volume":"9","author":"G Lanzolla","year":"2021","unstructured":"Lanzolla G, Sabini E, Leo M, Menconi F, Rocchi R, Sframeli A et al (2021) Statins for graves\u2019 orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial. Lancet Diabetes Endocrinol 9:733\u2013742","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2556_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cca.2017.12.032","volume":"478","author":"T Gojkovic","year":"2018","unstructured":"Gojkovic T, Vladimirov S, Spasojevic-Kalimanovska V, Zeljkovic A, Vekic J, Arsenijevic J et al (2018) Preanalytical and analytical challenges in gas chromatographic determination of cholesterol synthesis and absorption markers. Clin Chim Acta 478:74\u201381","journal-title":"Clin Chim Acta"},{"key":"2556_CR12","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/biom11121873","volume":"11","author":"UN Das","year":"2021","unstructured":"Das UN (2021) Essential fatty acids and their metabolites in the pathobiology of inflammation and its resolution. Biomolecules 11:1873","journal-title":"Biomolecules"},{"key":"2556_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/biomedicines12040883","volume":"12","author":"B Subo\u0161i\u0107","year":"2024","unstructured":"Subo\u0161i\u0107 B, Kotur-Stevuljevi\u0107 J, Bogavac-Stanojevi\u0107 N, Zdravkovi\u0107 V, Je\u0161i\u0107 M, Kova\u010devi\u0107 S et al (2024) Circulating fatty acids associate with metabolic changes in adolescents living with obesity. Biomedicines 12:883","journal-title":"Biomedicines"},{"key":"2556_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3389\/fendo.2019.00933","volume":"10","author":"G Lanzolla","year":"2020","unstructured":"Lanzolla G, Vannucchi G, Ionni I, Campi I, Sileo F, Lazzaroni E et al (2020) Cholesterol serum levels and use of Statins in graves\u2019 orbitopathy: A new starting point for the therapy. Front Endocrinol (Lausanne) 10:933","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2556_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00011-019-01273-5","volume":"68","author":"J Korbecki","year":"2019","unstructured":"Korbecki J, Bajdak-Rusinek K (2019) The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms. Inflamm Res 68:915\u2013932","journal-title":"Inflamm Res"},{"key":"2556_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH (2018) 2018 European thyroid association guideline for the management of graves\u2019. hyperthyroidism(Eur Thyroid J 7:167\u2013186","journal-title":"hyperthyroidism(Eur Thyroid J"},{"key":"2556_CR17","doi-asserted-by":"publisher","first-page":"e13608","DOI":"10.1111\/ijcp.13608","volume":"74","author":"B Nedeljkovic Beleslin","year":"2020","unstructured":"Nedeljkovic Beleslin B, Ciric J, Stojkovic M, Savic S, Lalic T, Stojanovic M et al (2020) Comparison of efficacy and safety of parenteral versus parenteral and oral glucocorticoid therapy in graves\u2019 orbitopathy. Int J Clin Pract 74:e13608","journal-title":"Int J Clin Pract"},{"key":"2556_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0889-8529(18)30485-7","volume":"16","author":"RS Bahn","year":"1987","unstructured":"Bahn RS, Gorman C (1987) Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 16:391\u2013407","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2556_CR19","doi-asserted-by":"crossref","unstructured":"Dickinson AJ (2007 ) Clinical manifestations. In: Wiersinga WM, Kahaly GJ (eds) Graves\u2019 orbitopathy: a multisciplinary approach. Karger, Bas page:1-26","DOI":"10.1159\/000107442"},{"key":"2556_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Grave\u2019s ophthalmopathy. Clin Endocrinol (Oxf) 47:9\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2556_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2249.2010.04266.x","volume":"162","author":"SD Lytton","year":"2010","unstructured":"Lytton SD, Li Y, Olivo PD, Kohn LD, Kahaly GJ (2010) Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating Immunoglobulins. Clin Exp Immunol 162:438\u2013446","journal-title":"Clin Exp Immunol"},{"key":"2556_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"2556_CR23","doi-asserted-by":"publisher","first-page":"e12045","DOI":"10.1371\/journal.pone.0012045","volume":"5","author":"C Glaser","year":"2010","unstructured":"Glaser C, Demmelmair H, Koletzko B (2010) High-throughput analysis of total plasma fatty acid composition with direct in situ transesterification. PLoS ONE 5:e12045","journal-title":"PLoS ONE"},{"key":"2556_CR24","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/B978-0-323-18907-1.00082-2","volume-title":"Endocrinology adult and pediatrics","author":"M Marin\u00f2","year":"2016","unstructured":"Marin\u00f2 M, Vitti P, Chiovato L (2016) Graves\u2019 disease. In: Jameson JL, De Groot LJ (eds) Endocrinology adult and pediatrics, 7th edn. Elsevier, Philadelphia, PA, pp 1437\u20131464","edition":"7"},{"key":"2556_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1297\/cpe.23.17","volume":"23","author":"S Takakuwa","year":"2014","unstructured":"Takakuwa S, Kina Y (2014) Clinical trial of four weeks of combination therapy with Low-dose methimazole and a cholesterol absorption inhibitor as the initial treatment for Childhood-onset graves\u2019 disease. Clin Pediatr Endocrinol 23:17\u201325","journal-title":"Clin Pediatr Endocrinol"},{"key":"2556_CR26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s40618-018-0915-z","volume":"41","author":"G Lanzolla","year":"2018","unstructured":"Lanzolla G, Sabini E, Profilo MA, Mazzi B, Sframeli A, Rocchi R et al (2018) Relationship between serum cholesterol and graves\u2019 orbitopathy (GO): a confirmatory study. J Endocrinol Invest 41:1417\u20131423","journal-title":"J Endocrinol Invest"},{"key":"2556_CR27","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1210\/clinem\/dgab070","volume":"106","author":"A Nilsson","year":"2021","unstructured":"Nilsson A, Tsoumani K, Planck T (2021) Statins decrease the risk of orbitopathy in newly diagnosed patients with graves\u2019 disease. J Clin Endocrinol Metab 106:1325\u20131332","journal-title":"J Clin Endocrinol Metab"},{"key":"2556_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1089\/thy.2017.0430","volume":"28","author":"E Sabini","year":"2018","unstructured":"Sabini E, Mazzi B, Profilo MA, Mautone T, Casini G, Rocchi R et al (2018) High serum cholesterol is a novel risk factor for graves\u2019 orbitopathy: results of a Cross-Sectional study. Thyroid 28:386\u2013394","journal-title":"Thyroid"},{"key":"2556_CR29","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2174\/0929867325666180530110543","volume":"26","author":"A Pirillo","year":"2019","unstructured":"Pirillo A, Catapano AL, Norata GD (2019) Biological consequences of dysfunctional HDL. Curr Med Chem 26:1644\u20131664","journal-title":"Curr Med Chem"},{"key":"2556_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40618-021-01652-y","volume":"45","author":"M Sari\u0107 Matutinovi\u0107","year":"2022","unstructured":"Sari\u0107 Matutinovi\u0107 M, Diana T, Nedeljkovi\u0107 Beleslin B, \u0106iri\u0107 J, \u017darkovi\u0107 M, Kahaly GJ et al (2022) Clinical value of functional Thyrotropin receptor antibodies in Serbian patients with graves\u2019 orbitopathy. J Endocrinol Invest 45:189\u2013197","journal-title":"J Endocrinol Invest"},{"key":"2556_CR31","doi-asserted-by":"publisher","first-page":"e07999","DOI":"10.7554\/eLife.07999","volume":"4","author":"MA Mitsche","year":"2015","unstructured":"Mitsche MA, McDonald JG, Hobbs HH, Cohen JC (2015) Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways. Elife 4:e07999","journal-title":"Elife"},{"key":"2556_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ca.10011","volume":"15","author":"R Wolfram-Gabel","year":"2002","unstructured":"Wolfram-Gabel R, Kahn JL (2002) Adipose body of the orbit. Clin Anat 15:186\u2013192","journal-title":"Clin Anat"},{"key":"2556_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","volume":"87","author":"TJ Smith","year":"2002","unstructured":"Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP et al (2002) Orbital fibroblast heterogeneity May determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 87:385\u2013392","journal-title":"J Clin Endocrinol Metab"},{"key":"2556_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1210\/jc.2003-031427","volume":"89","author":"S Kumar","year":"2004","unstructured":"Kumar S, Coenen MJ, Scherer PE, Bahn RS (2004) Evidence for enhanced adipogenesis in the orbits of patients with graves\u2019 ophthalmopathy. J Clin Endocrinol Metab 89:930\u2013935","journal-title":"J Clin Endocrinol Metab"},{"key":"2556_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","volume":"16","author":"PN Taylor","year":"2020","unstructured":"Taylor PN, Zhang L, Lee RWJ, Muller I, Ezra DG, Dayan CM et al (2020) New insights into the pathogenesis and nonsurgical management of graves orbitopathy. Nat Rev Endocrinol 16:104\u2013116","journal-title":"Nat Rev Endocrinol"},{"key":"2556_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/nu11010124","volume":"11","author":"S Mashnafi","year":"2019","unstructured":"Mashnafi S, Plat J, Mensink RP, Baumgartner S (2019) Non-Cholesterol sterol concentrations as biomarkers for cholesterol absorption and synthesis in different metabolic disorders: A systematic review. Nutrients 11:124","journal-title":"Nutrients"},{"key":"2556_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","volume":"133","author":"JD Stein","year":"2015","unstructured":"Stein JD, Childers D, Gupta S, Talwar N, Nan B, Lee BJ et al (2015) Risk factors for developing thyroid-associated ophthalmopathy among individuals with graves\u2019 disease. JAMA Ophthalmol 133:290\u2013296","journal-title":"JAMA Ophthalmol"},{"key":"2556_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bbrc.2005.11.099","volume":"339","author":"YC Kim","year":"2006","unstructured":"Kim YC, Song SB, Lee MH, Kang KI, Lee H, Paik SG et al (2006) Simvastatin induces caspase independent apoptosis in LPS-activated RAW264.7 macrophage cells. Biochem Biophys Res Commun 339:1007\u20131014","journal-title":"Biochem Biophys Res Commun"},{"key":"2556_CR39","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/bcp.12854","volume":"81","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Simental-Mend\u00eda LE, Pedone C, Ferretti G, Nachtigal P, Bo S et al (2016) Statin therapy and plasma free fatty acids: a systematic review and meta\u2010analysis of controlled clinical trials. Br J Clin Pharmacol 81:807\u2013818","journal-title":"Br J Clin Pharmacol"},{"key":"2556_CR40","doi-asserted-by":"publisher","first-page":"9145","DOI":"10.3390\/ijms21239145","volume":"21","author":"L Zhang","year":"2020","unstructured":"Zhang L, Evans A, von Ruhland C, Draman MS, Edkins S, Vincent AE et al (2020) Distinctive features of orbital adipose tissue (OAT) in graves\u2019 orbitopathy. Int J Mol Sci 21:9145","journal-title":"Int J Mol Sci"},{"key":"2556_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/nu15010224","volume":"15","author":"C Santa-Mar\u00eda","year":"2023","unstructured":"Santa-Mar\u00eda C, L\u00f3pez-Enr\u00edquez S, Montserrat-de la Paz S, Geniz I, Reyes-Quiroz ME, Moreno M et al (2023) Update on Anti-Inflammatory molecular mechanisms induced by oleic acid. Nutrients 15:224","journal-title":"Nutrients"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02556-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:50:27Z","timestamp":1751536227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02556-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2556"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02556-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The JGU Medical Center receives research-associated funding from GJK and GJK consults for Quidelortho, USA. SMM, SV, GT, DJI, J\u0106, SI and BNB have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All respondents signed an informed consent upon recruitment and an approval from the Ethics Committee of the Faculty of Pharmacy, University of Belgrade (944\/3: 17.06.2019.) was obtained prior to the beginning of the study. The Declaration of Helsinki, along with the principles of good clinical and laboratory practice, and applicable national and institutional regulations were followed during this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}